CASP8 and medulloblastoma: Furthermore, interferon-γ (IFNγ) treatment of caspase 8 deficient cells restored caspase 8 expression and TRAIL sensitivity in TRAIL-resistant medulloblastoma [34, 42] and neuroblastoma cell lines [27, 28, 43–46].